Who owns Harvard Bioscience?

Top Holders and Investors of HBIO Stock

Find out what company owns Harvard Bioscience, who bought HBIO this quarter, and who sold shares of HBIO stock?

Fund or Company Name Number of Shares Valued At As Of
First Light Asset Management 3.57M $9.11M Jun 2017
Heartland Advisors 2.10M $5.36M Jun 2017
Dimensional Fund Advisors 1.71M $4.36M Jun 2017
Royce & Associates 1.56M $3.97M Jun 2017
Vanguard 1.54M $3.87M Jun 2017
Glacier Peak Capital 1.32M $3.36M Jun 2017
BlackRock Institutional Trust Company, N.A. 1.16M $3.54M Dec 2016
Segall Bryant & Hamill 781276 $1.99M Jun 2017
Acadian Asset Management 735569 $1.88M Jun 2017
Bridgeway Capital Management 706217 $1.80M Jun 2017
Foundry Partners 684775 $1.75M Jun 2017
Renaissance Technologies 590000 $1.50M Jun 2017
Essex Investment Management 429460 $1.10M Jun 2017
Bard Associates 351822 $914737 Mar 2017
Jupiter Asset Management 335656 $855922 Jun 2017
Granahan Investment Management Inc/ma 297412 $758400 Jun 2017
Ameriprise Financial 294729 $751558 Jun 2017
Woodmont Investment Counsel 293694 $748919 Jun 2017
BlackRock Advisors 260927 $795827 Dec 2016
GSA Capital Partners 230019 $586548 Jun 2017
Axa 183300 $467415 Jun 2017
ClariVest Asset Management 159200 $405960 Jun 2017
Ancora Advisors 155578 $396723 Jun 2017
United Services Automobile Association 150792 $384519 Jun 2017
Geode Capital Management 146791 $374317 Jun 2017
CalPERS 139202 $354965 Jun 2017
Penbrook Managment 134100 $362070 Sep 2016
Eagle Global Advisors 131237 $334654 Jun 2017
First Manhattan 131000 $334050 Jun 2017
Algert Coldiron Investors 113818 $290235 Jun 2017
ICM Asset Management 109260 $278613 Jun 2017
Spark Investment Management 107200 $273360 Jun 2017
BlackRock Fund Advisors 104579 $318965 Dec 2016
Bank of America Corporation 99911 $259768 Mar 2017
Northern Trust 86205 $220684 Jun 2017
Technical Financial Services 40920 $103936 Jun 2017
Bank of New York Mellon 36830 $93916 Jun 2017
Goldman Sachs 32428 $83015 Jun 2017
D. E. Shaw & Co 29528 $75001 Jun 2017
White Pine Capital 28200 $71910 Jun 2017
T. Rowe Price Associates 28200 $71910 Jun 2017
BlackRock 26421 $81112 Dec 2016
Russell Investments 26158 $67487 Jun 2017
Emerald Acquisition 26158 $71411 Sep 2016
Two Sigma Advisers 25056 $64895 Mar 2017
Charles Schwab Investment Management 19300 $49987 Jun 2017
Balter Liquid Alternatives 19194 $48944 Jun 2017
State Street Corporation 14498 $36969 Jun 2017
Morgan Stanley 12783 $33619 Mar 2017
PanAgora Asset Management 12464 $32032 Jun 2017
Meristem 12368 $32033 Jun 2017
GRT Capital Partners 12000 $30960 Jun 2017
Two Sigma Investments 10704 $28044 Mar 2017
Nationwide Fund Advisors 8872 $22978 Mar 2017
JBF Capital 6200 $15996 Jun 2017
BlackRock Investment Management 5697 $16977 Dec 2016
UBS Group AG 3669 $8805 Jun 2017
Acrospire Investment Management 3506 $9010 Jun 2017
Manufacturers Life Insurance Company 1938 $5000 Jun 2017
Wells Fargo & Company 1535 $4006 Jun 2017
Creative Planning 810 $2000 Jun 2017
Ladenburg Thalmann Financial Services 300 $999 Jun 2017
Sei Investments 278 $1000 Jun 2017
Deutsche Bank Aktiengesellschaft 8 $0 Jun 2017
Bnp Paribas Arbitrage, Snc 2 $5 Jun 2017

Who sold Harvard Bioscience?

Fund Name Date Sold Shares Held Valued At
Kennedy Capital Management March 31, 2017 490909 $1.28M
Jacobs Levy Equity Management March 31, 2017 61473 $159829
Millennium Management March 31, 2017 16443 $43080
National Asset Management March 31, 2017 11801 $37409
Metlife Securities Sept. 30, 2016 10000 $27000
Walleye Trading March 31, 2017 6800 $18020
Royal Bank of Canada Dec. 31, 2016 61 $0